Concepedia
Statistics
Publications
14
Citations
1.3K
H-Index
Active since
2003
Affiliations
Yale University(Current)
Constellation Pharmaceuticals (United States)
Institute of Molecular Biology and Biophysics
Massachusetts General Hospital
Institute of Neurobiology
William D. Bradley is an author at Yale University specializing in medicine, cell biology, and signal transduction.
Top concepts
MedicineCell BiologySignal TransductionCell SignalingOncologyTumor BiologyCell PhysiologySystems BiologyMolecular BiologyCytoskeleton
Publications per year
2003–2021
Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer
Hong Yang, Brian Higgins, Kenneth Kolinsky et al. · Cancer Research · 2011 · 214 citations · Full text
Antitumor Activity, Cancer Biology, Tumor Biology +17
Resistance to Selective BRAF Inhibition Can Be Mediated by Modest Upstream Pathway Activation
Fei Su, William D. Bradley, Qiongqing Wang et al. · Cancer Research · 2011 · 177 citations
Cancer Biology, Tumor Biology, Signaling Pathway +16
Regulation of cell migration and morphogenesis by Abl-family kinases: emerging mechanisms and physiological contexts
William D. Bradley, Anthony J. Koleske · Journal of Cell Science · 2009 · 175 citations · Full text
Cytoskeleton, Actin Polymerization, Cellular Physiology +17
EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation
William D. Bradley, Shilpi Arora, Jennifer Busby et al. · Chemistry & Biology · 2014 · 148 citations
Hematological Malignancy, Lymphoid Neoplasia, Medicine +10
Inhibition of Rho via Arg and p190RhoGAP in the Postnatal Mouse Hippocampus Regulates Dendritic Spine Maturation, Synapse and Dendrite Stability, and Behavior
Mindan K. Sfakianos, Aaron S. Eisman, Shannon L. Gourley et al. · Journal of Neuroscience · 2007 · 124 citations · Full text
1–5 of 14